“There will be significant costs involved with getting approval for an OTC S3 product with the biggest hurdle identifying and proving the product is medically beneficial in some way”
they already have these costs covered in the most recent cap raise.
”Happy to hear the thoughts of others as always, I for one continue to be glad they are minimising debt and continue to raise money in other ways”.
I disagree. I would rather they avoid further dilution with any more cap raise and extend the debt facility. My bet/hope is they will get a variation from nab for the debt facility to include working capital and extend it ‘x’ million
to address previous post around being able to increase revenue 70% year over year, I say why not? Cann currently cultivate 1.5 tonne, next CY they will be cultivating 14tonne. That’s a lot more than 70% increase in product...
like I have said previously, it all comes down to how much product they can move.
- Forums
- ASX - By Stock
- CAN
- Will CANN group run out of money in 6 months?
Will CANN group run out of money in 6 months?, page-9
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CAN (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.0¢ |
Change
0.015(33.3%) |
Mkt cap ! $26.71M |
Open | High | Low | Value | Volume |
4.8¢ | 6.3¢ | 4.8¢ | $200.7K | 3.690M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6563 | 6.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.3¢ | 198391 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6563 | 0.060 |
1 | 12500 | 0.058 |
2 | 189634 | 0.057 |
1 | 40701 | 0.056 |
2 | 169060 | 0.055 |
Price($) | Vol. | No. |
---|---|---|
0.063 | 198391 | 2 |
0.064 | 167218 | 1 |
0.065 | 831157 | 3 |
0.069 | 7856 | 1 |
0.074 | 3000 | 1 |
Last trade - 15.57pm 27/09/2024 (20 minute delay) ? |
Featured News
CAN (ASX) Chart |